NCT05301764 2024-10-15
A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue Sarcoma
Lyvgen Biopharma Holdings Limited
Phase 1/2 Recruiting
Clinical Trials
5 trialsNCT04236362 2021-01-12
A Study of TQB2450 Combined With Anlotinib in Subjects With Gynecological Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown
NCT04273815 2020-07-08
A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown
NCT03825705 2019-10-31
A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown
NCT02558348 2019-06-19
AL3818
Advenchen Laboratories, LLC
Phase 1/2 Terminated